Scott Saunders, M.D., Ph.D.  saunders_s@kids.wustl.edu

Associate Professor of Pediatrics, Newborn Medicine
Developmental BiologyNewborn Medicine

phone: (314) 454-6148

Education

  • BS, University of Minnesota 1983
  • MD, Stanford University School of Medicine1990
  • PhD, Stanford University School of Medicine1990

Training

  • Intern in Medicine, Children's Hospital, Boston, MA1990 - 1991
  • Resident in Medicine, Children's Hospital, Boston, MA1991 - 1993
  • Postdoc Fellow, Brain & Cognitive Sciences , Massachusetts Institute of Technology, MA1993 - 1995
  • Clinical Fellow in Newborn Medicine, Joint Program in Neonatology, Harvard Medical School 1993 - 1996
  • Certified Medical Transport Executive, AAMS Medical Transport Leadership Institute2016 - 2017

Licensure and Board Certification

  • Federal Aviation Administration, Private Pilot, Airplane Single Engine Land 1980
  • National Board of Medical Examiners, Diplomate 1991
  • MA, Physician/Board of Registration in Medicine 1993
  • American Board of Pediatrics, General Pediatrics Certification 1993
  • MO, Physician & Surgeon/Board of Registration for the Healing Arts 1997
  • American Board of Pediatrics, Neonatal-Perinatal Medicine Certification 2008
  • IL, Physician & Surgeon/Dept. of Financial and Professional Regulation 2015
  • Advanced Trauma Life Support 2015
  • C-NPT (Neonatal Pediatric Transport) 2016
  • Neonatal Resuscitation Program 2016
  • Pediatric Advanced Life Support 2016
  • Advanced Cardiac Life Support 2016
  • Basic Life Support 2016
  • CEVO 3: Ambulance 2017
  • CMTE (Certified Medical Transport Executive) 2017

Honors

  • Alumni Scholarship, College of Biological Sciences, University of Minnesota1982
  • Phi Beta Kappa1983
  • Summa cum Laude, Biochemistry1983
  • Medical Student Research Award, Society for Pediatric Research1989
  • Howard Hughes Medical Institute Postdoctoral Research Fellowship for Physicians1994
  • Reynolds Rich Smith Fellowship in Development and Function of the Central Nervous System1994
  • Wyeth Pediatrics Neonatology Research Grant1994
  • Basil O'Connor Starter Scholar Research Award, March of Dimes Birth Defects Foundation1997
  • Scholar, NIH-designated Child Health Research Center, Washington University School of Medicine1997
  • Spoehrer Scholar Award, Department of Pediatrics, Washington University School of Medicine1999
  • Society for Pediatric Research, Member2001

Selected Publications view all (20)


Publication Co-Authors

1.
Wise regulates bone deposition through genetic interactions with Lrp5. PLoS One. 2014;9(5):e96257. doi:10.1371/journal.pone.0096257  PMCID:PMC4006890  PMID:24789067 
2.
Recurrent deletions and reciprocal duplications of 10q11.21q11.23 including CHAT and SLC18A3 are likely mediated by complex low-copy repeats. Hum Mutat. 2012;33(1):165-79. doi:10.1002/humu.21614  PMCID:PMC3655525  PMID:21948486 
3.
Sex-specific quantitative trait loci linked to autoresuscitation failure in SWR/J mice. Heredity (Edinb). 2009;103(6):469-75. doi:10.1038/hdy.2009.89  PMCID:PMC2783180  PMID:19654605 
4.
Loss of glypican-3 function causes growth factor-dependent defects in cardiac and coronary vascular development. Dev Biol. 2009;335(1):208-15. doi:10.1016/j.ydbio.2009.08.029  PMCID:PMC2763964  PMID:19733558 
5.
Bone density ligand, Sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity. J Bone Miner Res. 2006;21(11):1738-49. doi:10.1359/jbmr.060810  PMID:17002572 
6.
The rare occurrence of absent adrenals in a term infant: a case report and review of the literature. Am J Perinatol. 2006;23(2):111-4. doi:10.1055/s-2006-931911  PMID:16506117 
7.
Allelic variation in the serotonin transporter (5HTT) gene contributes to idiopathic pulmonary hypertension in children. Biochem Biophys Res Commun. 2005;334(2):376-9. doi:10.1016/j.bbrc.2005.06.107  PMID:16009349 
8.
Altered hematopoiesis in glypican-3-deficient mice results in decreased osteoclast differentiation and a delay in endochondral ossification. Dev Biol. 2005;282(1):152-62. doi:10.1016/j.ydbio.2005.03.003  PMID:15936336 
9.
Domain-specific modification of heparan sulfate by Qsulf1 modulates the binding of the bone morphogenetic protein antagonist Noggin. J Biol Chem. 2004;279(7):5604-11. doi:10.1074/jbc.M310691200  PMID:14645250 
10.
Heparan sulfate proteoglycans retain Noggin at the cell surface: a potential mechanism for shaping bone morphogenetic protein gradients. J Biol Chem. 2002;277(3):2089-96. doi:10.1074/jbc.M109151200  PMID:11706034 
© 2017 by Washington University in St. Louis
One Brookings Drive, St. Louis, MO 63130